2758-98-7 Usage
General Description
2-Piperazinecarboxylic acid methyl ester, also known as methyl 2-piperazinecarboxylate, is a chemical compound commonly used in the pharmaceutical industry. It is a methyl ester derivative of 2-piperazinecarboxylic acid, which is a building block for many pharmaceutical drugs. 2-Piperazinecarboxylic acid methyl ester is known for its potential use as a precursor in the synthesis of various pharmaceuticals, such as antihistamines and antipsychotic drugs. It also has potential applications in the development of new drug candidates. However, careful handling and storage of this chemical are necessary due to its potential hazards, and it should only be used by qualified personnel in a controlled laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 2758-98-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,5 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2758-98:
(6*2)+(5*7)+(4*5)+(3*8)+(2*9)+(1*8)=117
117 % 10 = 7
So 2758-98-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H12N2O2/c1-10-6(9)5-4-7-2-3-8-5/h5,7-8H,2-4H2,1H3
2758-98-7Relevant articles and documents
KRAS G12C INHIBITORS
-
Paragraph 0251, (2020/03/23)
The present invention relates to compounds that, inhibit KRas G12C, In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
KRAS G12C INHIBITORS
-
Paragraph 0213, (2017/12/18)
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
IMIDAZO [4, 5 - B] PYRIDINE DERIVATIVES AS ALK AND JAK MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
-
Page/Page column 207; 208, (2013/08/15)
This application relates to compounds of the Formula I as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders.